Zelira Therapeutics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 0.301121 million compared to AUD 1.54 million a year ago. Net loss was AUD 5.57 million compared to AUD 11.95 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 AUD | -0.70% | -0.70% | -21.67% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.67% | 5.22M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023